HTECvsIBBETF Comparison
ETF 1
HTEC
Robo Global Healthcare Technology and Innovation ETF
This fund is part of
Multiple Trends
-1.49%
VS
Robo Global Healthcare Technology and Innovation ETF (HTEC) belongs to the Multiple Trends segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. HTEC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. HTEC is more expensive with a Total Expense Ratio (TER) of 0.8%, versus 0.44% for IBB. HTEC is up 27.36% year-to-date (YTD) with +$41M in YTD flows. IBB performs better with 29.26% YTD performance, and +$800M in YTD flows. Run a side-by-side ETF comparison of HTEC and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
HTEC vs IBB performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HTEC IBB | +2.13%+3.30% | +19.57%+15.56% | +27.36%+29.26% | +36.59%+39.17% | +105.72%+94.23% | -0.81%+38.28% |
| Flows | HTEC IBB | +$34M+$502M | +$23M+$768M | +$41M+$800M | +$41M+$2.01B | +$10M+$155M | -$68M-$810M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HTEC IBB | +23.03%+26.22% | +21.26%+22.73% | +20.94%+21.40% | +24.28%+22.59% |
| Max drawdown | HTEC IBB | -6.70%-7.78% | -16.84%-9.61% | -22.68%-24.82% | -54.51%-35.62% |
| Max drawdown duration | HTEC IBB | 27d70d | 160d151d | 237d377d | 1819d1468d |
Trading data
HTEC | IBB | |
Last sale 10/29/2026 at 1:30 PM | $46.46 | $217.86 |
| Previous close 10/28/2026 | $46.01 | $216.35 |
| Consolidated volume 10/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
HTEC | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/29/2026 at 1:30 PM
Live
Closed
HTEC | IBB | |
|---|---|---|
| Last price | $46.46 | $217.86 |
| 1D performance | +0.98% | +0.70% |
| AuM | $112.88 M | $11.54 B |
| E/R | 0.8% | 0.44% |
Characteristics
HTEC | IBB | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | ROBO Global ETFs | iShares |
| Benchmark | ROBO Global Healthcare Technology and Innovation | NYSE Biotechnology Index |
| N° of holdings | 63 | 241 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 25, 2019 | February 5, 2001 |
| ESG | Yes | No |
Advertisement
Exposure
Countries
HTEC
USA
77.08%
Other
22.92%
IBB
USA
86.02%
Other
13.98%
Sectors
HTEC
Healthcare
95.03%
Other
4.97%
IBB
Healthcare
99.9%
Other
0.1%
Advertisement
Diversification
HTEC
Total weight of top 15 holdings out of 15
33.84%
IBB
Total weight of top 15 holdings out of 15
56.64%
Top 15 holdings
Data as of August 31, 2026
HTEC
Moderna, Inc.
3.43%
Twist Bioscience Corp.
3.06%
CareDx, Inc.
2.78%
Natera, Inc.
2.43%
Tempus AI, Inc.
2.12%
Thermo Fisher Scientific, Inc.
2.12%
IQVIA Holdings, Inc.
2.11%
Adaptive Biotechnologies Corp.
2.11%
Guardant Health, Inc.
2.06%
Vertex Pharmaceuticals, Inc.
1.98%
Medpace Holdings, Inc.
1.97%
Illumina, Inc.
1.96%
Axogen, Inc.
1.93%
Charles River Laboratories International, Inc.
1.92%
Regeneron Pharmaceuticals, Inc.
1.87%
IBB
Amgen, Inc.
8.45%
Vertex Pharmaceuticals, Inc.
8.05%
Gilead Sciences, Inc.
7.21%
Regeneron Pharmaceuticals, Inc.
5.72%
argenx SE
3.80%
Moderna, Inc.
3.62%
Natera, Inc.
3.12%
Revolution Medicines, Inc.
2.78%
Illumina, Inc.
2.29%
Alnylam Pharmaceuticals, Inc.
2.27%
Biogen, Inc.
2.25%
BeOne Medicines Ltd.
2.03%
Insmed, Inc.
1.85%
Incyte Corp.
1.73%
United Therapeutics Corp.
1.49%
Frequently asked questions about HTEC and IBB
How have the HTEC and IBB ETFs performed in 2026?
As of October 27, 2026, HTEC is up 27.36% year-to-date (YTD), while IBB has returned 29.26%. That puts IBB better performer ahead so far this year.
Which ETF is attracting more investor money: HTEC or IBB?
Year-to-date, the HTEC ETF saw +$41M in flows, compared to +$800M for IBB.
Which ETF is more volatile: HTEC or IBB?
Over the past year, HTEC had a volatility of 21.26%, while IBB experienced 22.73%.
Which ETF is bigger: HTEC or IBB?
As of October 27, 2026, HTEC holds $112.88 M in assets under management (AUM), while IBB manages $11.54 B.
What sectors do the HTEC and IBB ETFs invest in?
HTEC leans toward sectors like Healthcare. Meanwhile, IBB focuses on Healthcare.
What are the top holdings of the HTEC ETF and IBB ETF?
HTEC top holdings include Moderna, Inc., Twist Bioscience Corp. and CareDx, Inc.. IBB holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc..
Which ETF is more diversified: HTEC or IBB?
HTEC holds 63 securities with 33.84% of its assets in the top 15. IBB has 241 securities and a top 15 weight of 56.64%.
Advertisement
Latest news about HTEC & IBB
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
IBB
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
IBB
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
March 27, 2023
IBB
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IBB
Advertisement
Biggest potential ETF theme - Innovation
October 13, 2022
HTEC
Biggest potential ETF theme - Innovation
October 13, 2022
HTEC
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Advertisement
